SCHEMBL2989284

SCHEMBL2989284

CCc1nc2cc(C)ccn2c1Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 15/20 0.59
SMN1; SMN2 Q16637 9/20 0.59
KMT2A Q03164 4/20 0.59
HTT P42858 3/20 0.59
NPSR1 Q6W5P4 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
MITF O75030 1/20 0.59
MAPT P10636 11/20 0.55
TP53 P04637 6/20 0.55
THRB P10828 1/20 0.55
POLB P06746 3/20 0.52
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
PKM P14618 1/20 0.45
PKLR P30613 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
LMNA P02545 2/20 0.44
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2984318 0.90 GAA (0.57) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL1966588 0.83 PTGS2 (0.53) GAASMN1; SMN2HTTTDP1MAPT
SCHEMBL1967220 0.80 GAA (0.74) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL1967097 0.78 GAA (0.59) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL2986228 0.78 GAA (0.59) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL1969742 0.75 GAA (0.56) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL16452863 0.75 KDM4E (0.49) GAASMN1; SMN2MAPTTP53POLB
SCHEMBL1966521 0.74 GAA (0.66) GAASMN1; SMN2KMT2AHTTNPSR1
SCHEMBL2989281 0.73 ALDH1A1 (0.73) GAASMN1; SMN2HTTNPSR1MAPT
SCHEMBL2988605 0.73 GAA (0.61) GAASMN1; SMN2KMT2AHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US claimed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US disclosed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 GAA 820/4885SMN1; SMN2 46/4885KMT2A 4065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.